Biggest News Aggregation in the World
📰 Closing News

Page 1029 - Closing News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Closing. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces Dosing of First Patient in Phase 2 Gastric Cancer Trial of 4-1BB/HER2 Bispecific Cinrebafusp Alfa

BOSTON, MA / ACCESSWIRE / January 14, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology
United States Maria Kelman Tim Demuth Drug Administration Pieris Pharmaceuticals Company Quarterly Reports On Form

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science